₹180
(Inclusive of all Taxes)
₹27.0 Cashback (15%)
Prescription drugWhats That
Secure Payment
India's Most Trusted Pharmacy
Genuine Products
Also Explore
संघटन :
गैटीफ्लोक्सासिन-0.3% W/V
निर्माता/विपणक :
स्पष्ट रूप से प्राइवेट लिमिटेड देखें
उपभोग प्रकार :
नेत्र
वापसी नीति :
वापसी योग्य नहीं
को या उसके बाद समाप्त हो जाएगा :
Jan-27
Drug-Drug Interactions
GatifloxacinRosiglitazone
Critical
Critical
Drug-Drug Interactions
Login/Sign Up
GatifloxacinRosiglitazone
Critical
How does the drug interact with Orbigat-Hs 0.5%W/V Eye Drops 5ml:
Coadministration of Orbigat-Hs 0.5%W/V Eye Drops 5ml with Rosiglitazone may sometimes affect blood glucose levels. Both low blood glucose and, less frequently, high blood glucose have been reported.
How to manage the interaction:
Although there is a possible interaction, Rosiglitazone can be taken with Orbigat-Hs 0.5%W/V Eye Drops 5ml if prescribed by the doctor. Consult the prescriber if you experience symptoms such as nervousness, confusion, headache, dizziness, drowsiness, tremor, nausea, hunger, weakness, perspiration, palpitation, rapid heartbeat, increased urination, increased thirst, and increased hunger. Maintaining blood glucose levels is advised.
Coadministration of Orbigat-Hs 0.5%W/V Eye Drops 5ml with Rosiglitazone may sometimes affect blood glucose levels. Both low blood glucose and, less frequently, high blood glucose have been reported.
How to manage the interaction:
Although there is a possible interaction, Rosiglitazone can be taken with Orbigat-Hs 0.5%W/V Eye Drops 5ml if prescribed by the doctor. Consult the prescriber if you experience symptoms such as nervousness, confusion, headache, dizziness, drowsiness, tremor, nausea, hunger, weakness, perspiration, palpitation, rapid heartbeat, increased urination, increased thirst, and increased hunger. Maintaining blood glucose levels is advised.
Critical
How does the drug interact with Orbigat-Hs 0.5%W/V Eye Drops 5ml:
Co-administration of Pioglitazone with Orbigat-Hs 0.5%W/V Eye Drops 5ml may sometimes affect blood glucose levels. Both high blood glucose and, less frequently, low blood glucose have been reported.
How to manage the interaction:
Although there is a possible interaction, Pioglitazone can be taken with Orbigat-Hs 0.5%W/V Eye Drops 5ml if prescribed by the doctor. Consult the prescriber if you experience symptoms such as nervousness, confusion, headache, dizziness, drowsiness, tremors, nausea, hunger, weakness, excessive sweating, rapid heartbeat, increased urination, increased thirst, and increased hunger. Maintaining blood glucose levels is advised. Do not discontinue any medications without a doctor's advice.
Co-administration of Pioglitazone with Orbigat-Hs 0.5%W/V Eye Drops 5ml may sometimes affect blood glucose levels. Both high blood glucose and, less frequently, low blood glucose have been reported.
How to manage the interaction:
Although there is a possible interaction, Pioglitazone can be taken with Orbigat-Hs 0.5%W/V Eye Drops 5ml if prescribed by the doctor. Consult the prescriber if you experience symptoms such as nervousness, confusion, headache, dizziness, drowsiness, tremors, nausea, hunger, weakness, excessive sweating, rapid heartbeat, increased urination, increased thirst, and increased hunger. Maintaining blood glucose levels is advised. Do not discontinue any medications without a doctor's advice.
GatifloxacinTolazamide
Critical
How does the drug interact with Orbigat-Hs 0.5%W/V Eye Drops 5ml:
coadministration of Orbigat-Hs 0.5%W/V Eye Drops 5ml with Tolazamide may sometimes affect blood glucose levels. Both low blood glucose and, less frequently, high blood glucose have been reported.
How to manage the interaction:
Co-administration of Orbigat-Hs 0.5%W/V Eye Drops 5ml with Tolazamide is not recommended as it can possibly result in an interaction, but it can be taken if your doctor has advised it. Consult the prescriber if you experience symptoms such as nervousness, confusion, headache, dizziness, drowsiness, tremor, nausea, hunger, weakness, perspiration, palpitation, rapid heartbeat, increased urination, increased thirst, and increased hunger. Maintaining blood glucose levels is advised.
coadministration of Orbigat-Hs 0.5%W/V Eye Drops 5ml with Tolazamide may sometimes affect blood glucose levels. Both low blood glucose and, less frequently, high blood glucose have been reported.
How to manage the interaction:
Co-administration of Orbigat-Hs 0.5%W/V Eye Drops 5ml with Tolazamide is not recommended as it can possibly result in an interaction, but it can be taken if your doctor has advised it. Consult the prescriber if you experience symptoms such as nervousness, confusion, headache, dizziness, drowsiness, tremor, nausea, hunger, weakness, perspiration, palpitation, rapid heartbeat, increased urination, increased thirst, and increased hunger. Maintaining blood glucose levels is advised.
Critical
How does the drug interact with Orbigat-Hs 0.5%W/V Eye Drops 5ml:
Co-administration of Orbigat-Hs 0.5%W/V Eye Drops 5ml with Insulin detemir may sometimes affect blood glucose levels. Both low blood glucose and, less frequently, high blood glucose have been reported.
How to manage the interaction:
Although there is a possible interaction, Insulin detemir can be taken with Orbigat-Hs 0.5%W/V Eye Drops 5ml if prescribed by the doctor. Consult the prescriber if you experience symptoms such as nervousness, confusion, headache, dizziness, drowsiness, tremors, nausea, hunger, weakness, perspiration, palpitation, rapid heartbeat, increased urination, increased thirst, and increased hunger. Maintaining blood glucose levels is advised. Do not discontinue any medications without a doctor's advice.
Co-administration of Orbigat-Hs 0.5%W/V Eye Drops 5ml with Insulin detemir may sometimes affect blood glucose levels. Both low blood glucose and, less frequently, high blood glucose have been reported.
How to manage the interaction:
Although there is a possible interaction, Insulin detemir can be taken with Orbigat-Hs 0.5%W/V Eye Drops 5ml if prescribed by the doctor. Consult the prescriber if you experience symptoms such as nervousness, confusion, headache, dizziness, drowsiness, tremors, nausea, hunger, weakness, perspiration, palpitation, rapid heartbeat, increased urination, increased thirst, and increased hunger. Maintaining blood glucose levels is advised. Do not discontinue any medications without a doctor's advice.
GatifloxacinLiraglutide
Critical
How does the drug interact with Orbigat-Hs 0.5%W/V Eye Drops 5ml:
Coadministration of Liraglutide with Orbigat-Hs 0.5%W/V Eye Drops 5ml may sometimes affect blood glucose levels.
How to manage the interaction:
Liraglutide with Orbigat-Hs 0.5%W/V Eye Drops 5ml can cause an interaction but can be taken if prescribed by the doctor. Do not stop using any medications without talking to a doctor.
Coadministration of Liraglutide with Orbigat-Hs 0.5%W/V Eye Drops 5ml may sometimes affect blood glucose levels.
How to manage the interaction:
Liraglutide with Orbigat-Hs 0.5%W/V Eye Drops 5ml can cause an interaction but can be taken if prescribed by the doctor. Do not stop using any medications without talking to a doctor.
GatifloxacinHalofantrine
Critical
How does the drug interact with Orbigat-Hs 0.5%W/V Eye Drops 5ml:
Taking Orbigat-Hs 0.5%W/V Eye Drops 5ml with Halofantrine can increase the risk or severity of irregular heart rhythms. The risk increases in patients with a history of heart illness or electrolyte imbalance.
How to manage the interaction:
Taking Orbigat-Hs 0.5%W/V Eye Drops 5ml with Halofantrine together can possibly result in an interaction, it can be taken if your doctor has advised it. However, if you experience sudden dizziness, lightheadedness, fainting, shortness of breath, chest pain or tightness, rapid heartbeat, or memory loss, contact your doctor immediately. Do not discontinue any medications without consulting a doctor.
Taking Orbigat-Hs 0.5%W/V Eye Drops 5ml with Halofantrine can increase the risk or severity of irregular heart rhythms. The risk increases in patients with a history of heart illness or electrolyte imbalance.
How to manage the interaction:
Taking Orbigat-Hs 0.5%W/V Eye Drops 5ml with Halofantrine together can possibly result in an interaction, it can be taken if your doctor has advised it. However, if you experience sudden dizziness, lightheadedness, fainting, shortness of breath, chest pain or tightness, rapid heartbeat, or memory loss, contact your doctor immediately. Do not discontinue any medications without consulting a doctor.
Critical
How does the drug interact with Orbigat-Hs 0.5%W/V Eye Drops 5ml:
Taking Orbigat-Hs 0.5%W/V Eye Drops 5ml with Cisapride can increase the risk or severity of irregular heart rhythms. The risk increases in patients with a history of heart illness or electrolyte imbalance.
How to manage the interaction:
Taking Orbigat-Hs 0.5%W/V Eye Drops 5ml with Cisapride together is not recommended as it can possibly result in an interaction, it can be taken if your doctor has advised it. However, if you experience sudden dizziness, lightheadedness, fainting, shortness of breath, chest pain or tightness, rapid heartbeat, or memory loss, contact your doctor immediately. Do not discontinue any medications without consulting a doctor.
Taking Orbigat-Hs 0.5%W/V Eye Drops 5ml with Cisapride can increase the risk or severity of irregular heart rhythms. The risk increases in patients with a history of heart illness or electrolyte imbalance.
How to manage the interaction:
Taking Orbigat-Hs 0.5%W/V Eye Drops 5ml with Cisapride together is not recommended as it can possibly result in an interaction, it can be taken if your doctor has advised it. However, if you experience sudden dizziness, lightheadedness, fainting, shortness of breath, chest pain or tightness, rapid heartbeat, or memory loss, contact your doctor immediately. Do not discontinue any medications without consulting a doctor.
GatifloxacinTolbutamide
Critical
How does the drug interact with Orbigat-Hs 0.5%W/V Eye Drops 5ml:
Coadministration of Orbigat-Hs 0.5%W/V Eye Drops 5ml and Tolbutamide may sometimes affect blood glucose levels. Both high blood glucose and, less frequently, low blood glucose have been reported.
How to manage the interaction:
There may be a possibility of interaction between Orbigat-Hs 0.5%W/V Eye Drops 5ml and Tolbutamide, but it can be taken if prescribed by a doctor. Consult the prescriber if you experience symptoms such as nervousness, confusion, headache, dizziness, drowsiness, tremors, nausea, hunger, weakness, perspiration, palpitation, rapid heartbeat, increased urination, increased thirst, and increased hunger. Maintaining blood glucose levels is advised.
Coadministration of Orbigat-Hs 0.5%W/V Eye Drops 5ml and Tolbutamide may sometimes affect blood glucose levels. Both high blood glucose and, less frequently, low blood glucose have been reported.
How to manage the interaction:
There may be a possibility of interaction between Orbigat-Hs 0.5%W/V Eye Drops 5ml and Tolbutamide, but it can be taken if prescribed by a doctor. Consult the prescriber if you experience symptoms such as nervousness, confusion, headache, dizziness, drowsiness, tremors, nausea, hunger, weakness, perspiration, palpitation, rapid heartbeat, increased urination, increased thirst, and increased hunger. Maintaining blood glucose levels is advised.
Critical
How does the drug interact with Orbigat-Hs 0.5%W/V Eye Drops 5ml:
Coadministration of Semaglutide with Orbigat-Hs 0.5%W/V Eye Drops 5ml may sometimes affect blood glucose levels. Both low blood glucose and, less frequently, high blood glucose have been reported.
How to manage the interaction:
Although there is a possible interaction, Semaglutide can be taken with Orbigat-Hs 0.5%W/V Eye Drops 5ml if prescribed by the doctor. Consult the doctor if you experience symptoms such as nervousness, confusion, headache, dizziness, drowsiness, tremor, nausea, hunger, weakness, perspiration, palpitation, rapid heartbeat, increased urination, increased thirst, and increased hunger. Maintaining blood glucose levels is advised. Do not discontinue any medications without first consulting your doctor.
Coadministration of Semaglutide with Orbigat-Hs 0.5%W/V Eye Drops 5ml may sometimes affect blood glucose levels. Both low blood glucose and, less frequently, high blood glucose have been reported.
How to manage the interaction:
Although there is a possible interaction, Semaglutide can be taken with Orbigat-Hs 0.5%W/V Eye Drops 5ml if prescribed by the doctor. Consult the doctor if you experience symptoms such as nervousness, confusion, headache, dizziness, drowsiness, tremor, nausea, hunger, weakness, perspiration, palpitation, rapid heartbeat, increased urination, increased thirst, and increased hunger. Maintaining blood glucose levels is advised. Do not discontinue any medications without first consulting your doctor.
Critical
How does the drug interact with Orbigat-Hs 0.5%W/V Eye Drops 5ml:
Taking Orbigat-Hs 0.5%W/V Eye Drops 5ml with Dronedarone can increase the risk or severity of irregular heart rhythms. The risk increases in patients with a history of heart illness or electrolyte imbalance.
How to manage the interaction:
Taking Orbigat-Hs 0.5%W/V Eye Drops 5ml with Dronedarone together is not recommedned as it can possibly result in an interaction, it can be taken if your doctor has advised it. However, if you experience sudden dizziness, lightheadedness, fainting, shortness of breath, chest pain or tightness, rapid heartbeat, or memory loss, contact your doctor immediately. Do not discontinue any medications without consulting a doctor.
Taking Orbigat-Hs 0.5%W/V Eye Drops 5ml with Dronedarone can increase the risk or severity of irregular heart rhythms. The risk increases in patients with a history of heart illness or electrolyte imbalance.
How to manage the interaction:
Taking Orbigat-Hs 0.5%W/V Eye Drops 5ml with Dronedarone together is not recommedned as it can possibly result in an interaction, it can be taken if your doctor has advised it. However, if you experience sudden dizziness, lightheadedness, fainting, shortness of breath, chest pain or tightness, rapid heartbeat, or memory loss, contact your doctor immediately. Do not discontinue any medications without consulting a doctor.
Drug-Food Interactions
No Drug - Food interactions found in our database. Some may be unknown. Consult your doctor for what to avoid during medication.
Drug-Food Interactions
Login/Sign Up
ऑर्बिगैट-एचएस 0.5%W/V आई ड्रॉप्स 5ml Substitute
Product Substitutes
शराब
Caution
ऑर्बिगैट-एचएस 0.5%W/V आई ड्रॉप्स 5ml के साथ शराब का इंटरैक्शन ज्ञात नहीं है। ऑर्बिगैट-एचएस 0.5%W/V आई ड्रॉप्स 5ml के साथ उपचार के दौरान शराब का सेवन करने से पहले अपने डॉक्टर से परामर्श करें।
गर्भावस्था
Caution
यह ज्ञात नहीं है कि ऑर्बिगैट-एचएस 0.5%W/V आई ड्रॉप्स 5ml गर्भवती महिलाओं को प्रभावित करेगा या नहीं। इसलिए, यदि आप गर्भवती हैं तो ऑर्बिगैट-एचएस 0.5%W/V आई ड्रॉप्स 5ml का उपयोग करने से पहले डॉक्टर से परामर्श लें।
स्तनपान
Caution
यह अज्ञात है कि ऑर्बिगैट-एचएस 0.5%W/V आई ड्रॉप्स 5ml स्तन के दूध में जाता है या नहीं। यदि आप स्तनपान करा रही हैं तो ऑर्बिगैट-एचएस 0.5%W/V आई ड्रॉप्स 5ml लेने से पहले अपने डॉक्टर से परामर्श करें।
ड्राइविंग
Caution
ऑर्बिगैट-एचएस 0.5%W/V आई ड्रॉप्स 5ml आमतौर पर अस्थायी रूप से धुंधली दृष्टि का कारण बनता है। इसलिए, जब तक आपकी दृष्टि स्पष्ट न हो जाए, तब तक गाड़ी चलाने या मशीनरी चलाने से बचें।
जिगर
Caution
यदि आपको लीवर संबंधी कोई समस्या है तो कृपया अपने डॉक्टर से परामर्श करें।
किडनी
Caution
यदि आपको किडनी से संबंधित कोई समस्या है तो कृपया अपने डॉक्टर से परामर्श करें।
बच्चे
Caution
ऑर्बिगैट-एचएस 0.5%W/V आई ड्रॉप्स 5ml 1 वर्ष से कम उम्र के बच्चों के लिए अनुशंसित नहीं है। हालाँकि, बच्चों को ऑर्बिगैट-एचएस 0.5%W/V आई ड्रॉप्स 5ml देने से पहले कृपया डॉक्टर से सलाह लें।
Have a query?
Disclaimer
While we strive to provide complete, accurate, and expert-reviewed content on our 'Platform', we make no warranties or representations and disclaim all responsibility and liability for the completeness, accuracy, or reliability of the aforementioned content. The content on our platform is for informative purposes only, and may not cover all clinical/non-clinical aspects. Reliance on any information and subsequent action or inaction is solely at the user's risk, and we do not assume any responsibility for the same. The content on the Platform should not be considered or used as a substitute for professional and qualified medical advice. Please consult your doctor for any query pertaining to medicines, tests and/or diseases, as we support, and do not replace the doctor-patient relationship.
Author Details
